C-Peptide: A New Mediator of Atherosclerosis in Diabetes
Diabetes type 2 and insulin resistance are the risk factors for cardiovascular disease. It is already known that atherosclerosis is an inflammatory disease, and a lot of different factors are involved in its onset. C-peptide is a cleavage product of proinsulin, an active substance with a number of e...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2012/858692 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832561019153547264 |
|---|---|
| author | Dusica Vasic Daniel Walcher |
| author_facet | Dusica Vasic Daniel Walcher |
| author_sort | Dusica Vasic |
| collection | DOAJ |
| description | Diabetes type 2 and insulin resistance are the risk factors for cardiovascular disease. It is already known that atherosclerosis is an inflammatory disease, and a lot of different factors are involved in its onset. C-peptide is a cleavage product of proinsulin, an active substance with a number of effects within different complications of diabetes. In this paper we discuss the role of C-peptide and its effects in the development of atherosclerosis in type 2 diabetic patients. |
| format | Article |
| id | doaj-art-712270dc17c3485884b875c8d37a55c4 |
| institution | Kabale University |
| issn | 0962-9351 1466-1861 |
| language | English |
| publishDate | 2012-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Mediators of Inflammation |
| spelling | doaj-art-712270dc17c3485884b875c8d37a55c42025-02-03T01:26:06ZengWileyMediators of Inflammation0962-93511466-18612012-01-01201210.1155/2012/858692858692C-Peptide: A New Mediator of Atherosclerosis in DiabetesDusica Vasic0Daniel Walcher1Department of Internal Medicine II-Cardiology, University of Ulm, Albert-Einstein-Allee 11, 89081 Ulm, GermanyDepartment of Internal Medicine II-Cardiology, University of Ulm, Albert-Einstein-Allee 11, 89081 Ulm, GermanyDiabetes type 2 and insulin resistance are the risk factors for cardiovascular disease. It is already known that atherosclerosis is an inflammatory disease, and a lot of different factors are involved in its onset. C-peptide is a cleavage product of proinsulin, an active substance with a number of effects within different complications of diabetes. In this paper we discuss the role of C-peptide and its effects in the development of atherosclerosis in type 2 diabetic patients.http://dx.doi.org/10.1155/2012/858692 |
| spellingShingle | Dusica Vasic Daniel Walcher C-Peptide: A New Mediator of Atherosclerosis in Diabetes Mediators of Inflammation |
| title | C-Peptide: A New Mediator of Atherosclerosis in Diabetes |
| title_full | C-Peptide: A New Mediator of Atherosclerosis in Diabetes |
| title_fullStr | C-Peptide: A New Mediator of Atherosclerosis in Diabetes |
| title_full_unstemmed | C-Peptide: A New Mediator of Atherosclerosis in Diabetes |
| title_short | C-Peptide: A New Mediator of Atherosclerosis in Diabetes |
| title_sort | c peptide a new mediator of atherosclerosis in diabetes |
| url | http://dx.doi.org/10.1155/2012/858692 |
| work_keys_str_mv | AT dusicavasic cpeptideanewmediatorofatherosclerosisindiabetes AT danielwalcher cpeptideanewmediatorofatherosclerosisindiabetes |